Enhancing meningioma resection: a comprehensive study on the safety and effectiveness of Onyx™ presurgical embolization

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
BATISTA, Savio
ANDREAO, Filipi Fim
PALAVANI, Lucca B.
BORGES, Pedro
VERLY, Gabriel
FILHO, Jose Alberto Almeida
ABREU, Livia V. de
PESSOA, Bruno L.
Citação
NEUROSURGICAL REVIEW, v.46, n.1, article ID 299, 11p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Presurgical embolization (PE) has emerged as an interesting strategy to help turn brain tumor resection more amenable. This study aims to systematically review the safety and effectiveness of Onyx (TM) PE in meningioma resection. We followed Cochrane Collaboration and PRISMA for systematic review and meta-analysis, querying PUBMED, Cochrane Library, Web of Science, and Embase databases. Major complications were defined as other artery occlusion, visual deficits due to PE, or non temporary nerve damage, while minor included transitory conditions and others without clinical implications. A total of 186 patients were included, in which 120 were WHO grade I (80%), II (16%), and III (4%). Patient baseline characteristics and complications were distributed in groups without or with individual patient data analysis. Individual Patient Data Meta-Analysis (IPDMA) was performed on the last category, comprising 51 meningiomas that underwent Onyx (TM) PE. Among available data, 70%, 17%, and 13% were WHO grade I, II, and III, respectively. Considering all studies, tumor characteristics regarding grade underscored a certain homogeneity. Complications occurred at a rate of 9% (95% CI, 4 to 14%; I2 = 35%), with the rate of major complications significantly lower at only 1% (95% CI, 0 to 3%; I2 = 32%), whereas of minor complications was 7% (95% CI, 3 to 10%; I2 = 0%). Mean surgery blood loss was 668.7 (95% CI, 534.9 to 835.8; I2 = 0%) in IPDMA. Onyx (TM) PE is promising for safer surgical meningioma resection, despite limitations. Further studies are required to validate efficacy, enhance patient selection, and refine techniques.
Palavras-chave
Meningioma, Onyx, EVOH, Presurgical, Embolization
Referências
  1. Almefty RO, 2017, WORLD NEUROSURG, V102, P157, DOI 10.1016/j.wneu.2017.02.092
  2. Bendszus M, 2000, NEUROSURGERY, V47, P1306, DOI 10.1097/00006123-200012000-00008
  3. DEAN BL, 1994, AM J NEURORADIOL, V15, P1675
  4. Dubel GJ, 2013, SEMIN INTERVENT RAD, V30, P263, DOI 10.1055/s-0033-1353479
  5. Elhammady MS, 2012, WORLD NEUROSURG, V77, P725, DOI 10.1016/j.wneu.2011.02.033
  6. Elhammady MS, 2010, J NEUROSURG, V112, P1039, DOI 10.3171/2009.7.JNS09351
  7. Felbaum DR, 2016, CUREUS J MED SCIENCE, V8, DOI 10.7759/cureus.776
  8. Friconnet G, 2020, J NEURORADIOLOGY, V47, P355, DOI 10.1016/j.neurad.2019.05.012
  9. Fusco Matthew R, 2016, J Cerebrovasc Endovasc Neurosurg, V18, P12, DOI 10.7461/jcen.2016.18.1.12
  10. Gobin YP, 2001, RADIOLOGY, V221, P309, DOI 10.1148/radiol.2212001140
  11. Gore P, 2008, NEUROSURGERY, V62, P1204, DOI 10.1227/01.neu.0000333292.74986.ac
  12. Grandhi R, 2015, J NEUROL SURG PART A, V76, P309, DOI 10.1055/s-0034-1394191
  13. Guimaraes Marcelo, 2011, Semin Intervent Radiol, V28, P350, DOI 10.1055/s-0031-1284462
  14. Ierardi Anna Maria, 2020, Acta Biomed, V91, P71, DOI 10.23750/abm.v91i8-S.9974
  15. Jack AS, 2016, CAN J NEUROL SCI, V43, P206, DOI 10.1017/cjn.2015.264
  16. James RF, 2016, NEUROSURG CLIN N AM, V27, P155, DOI 10.1016/j.nec.2015.11.005
  17. Kerim AA, 2010, J NEUROSURG, V112, P70, DOI 10.3171/2008.11.JNS08175
  18. Kominami S, 2012, INTERV NEURORADIOL, V18, P133, DOI 10.1177/159101991201800202
  19. Lacobucci M, 2017, DIAGN INTERV IMAG, V98, P307, DOI 10.1016/j.diii.2016.08.006
  20. Przybylowski CJ, 2021, J NEUROSURG, V134, P693, DOI 10.3171/2020.1.JNS19788
  21. Przybylowski CJ, 2018, WORLD NEUROSURG, V116, pE371, DOI 10.1016/j.wneu.2018.04.208
  22. Rangel-Castilla L, 2014, J NEUROINTERV SURG, V6, P51, DOI 10.1136/neurintsurg-2012-010542
  23. Raper DMS, 2014, AM J NEURORADIOL, V35, P1798, DOI 10.3174/ajnr.A3919
  24. Rossitti S, 2007, ACTA RADIOL, V48, P321, DOI 10.1080/02841850601161547
  25. Shah AH, 2013, J NEUROSURG, V119, P364, DOI 10.3171/2013.3.JNS121328
  26. Shi ZS, 2008, SURG NEUROL, V70, P478, DOI 10.1016/j.surneu.2007.05.031
  27. Siekmann R, 2005, INTERV NEURORADIOL, V11, P131, DOI 10.1177/15910199050110S117
  28. Silva MA, 2020, NEUROCIRUGIA, V31, P173, DOI 10.1016/j.neucir.2019.10.003
  29. Spiotta AM, 2014, J NEUROINTERV SURG, V6, P547, DOI 10.1136/neurintsurg-2013-010833
  30. Torres G, 2019, J NEURO-OPHTHALMOL, V39, P520, DOI 10.1097/WNO.0000000000000772
  31. Trivelatto F, 2011, AM J NEURORADIOL, V32, P1762, DOI 10.3174/ajnr.A2591
  32. Velez AM, 2011, NEUROSURGERY, V68, pE1165, DOI 10.1227/NEU.0b013e31820a181a
  33. Wen LL, 2017, J NEUROINTERV SURG, V9, P1139, DOI 10.1136/neurintsurg-2016-012658
  34. Younes S, 2022, CAN J OPHTHALMOL, V57, pE136, DOI 10.1016/j.jcjo.2021.12.001
  35. Zacharewski Nicholas, 2022, J Neurol Surg Rep, V83, pe44, DOI 10.1055/s-0042-1749215